The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults
- 31 October 2007
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 64 (1), 19-30
- https://doi.org/10.1016/j.critrevonc.2007.07.003
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:Cancer, 2006
- Disease biology rather than age is the most important determinant of survival of patients ≥ 60 years with acute myeloid leukemia treated with uniform intensive therapyCancer, 2005
- Prognostic features for response and survival in elderly patients withde novoacute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabineLeukemia & Lymphoma, 2005
- The Outcomes and Costs of Acute Myeloid Leukemia Among the ElderlyArchives of Internal Medicine, 2002
- The challenge of acute myeloid leukemia in older patientsCurrent Opinion in Oncology, 2002
- Acute myeloid leukemia in the elderly: biology and therapeutic strategiesCritical Reviews in Oncology/Hematology, 2001
- Management of Acute Myeloid Leukemia in Elderly PatientsJournal of Clinical Oncology, 1999
- 8 Treatment of the elderly patient with acute myeloid leukaemiaBailliere's Clinical Haematology, 1996
- Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Acute leukaemiasBailliere's Clinical Haematology, 1992